Blood and Urine Sample Collection From Healthy Volunteers
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy
- Sponsor
- Evotec International GmbH
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Collection of blood samples from healthy volunteers to serve as a healthy control group.
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The aim of the study is to obtain blood and urine samples from healthy volunteers to serve as a healthy control group for cross-cohort comparisons.
Detailed Description
The aim of the study is to obtain peripheral venous blood samples and a urine sample from 100 healthy volunteers on one day at three different times of the day, to serve as a healthy control group for cross-cohort comparisons. With the help of the urine and blood samples obtained in this context, a cohort of a healthy collective is to be established for further research purposes.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy male and female subjects aged 40-70 years.
- •Caucasian
- •Non-smokers or ex-smokers
- •Body Mass Index (BMI): ≥18.5 and ≤32 kg/m2
- •Presence of a negative SARS-CoV-2 PCR test.
Exclusion Criteria
- •Complaints that may indicate the presence of an infection, including Covid-
- •Pathological alcohol consumption.
- •Positive alcohol breath test at the preliminary examination.
- •Alcohol consumption within the last 24 hours before the start of sampling.
- •History of drug dependence.
- •Positive urine drug test during the preliminary examination.
- •Clinically significant acute or chronic disease. In particular, chronic inflammation, rheumatological and other autoimmune diseases, diabetes and other metabolic diseases.
- •Indications in the medical history or during the medical examination that may jeopardize the safety of the study participant by participating in the study.
- •History of relevant clinically significant cardiovascular disorders or clinically relevant hyper- or hypotension or clinically relevant brady- or tachycardia at screening as assessed by an investigator.
- •Heart rate \<45/min after 5 minutes in a quiet sitting position.
Outcomes
Primary Outcomes
Collection of blood samples from healthy volunteers to serve as a healthy control group.
Time Frame: 1 day
There are no primary endpoints planned; endpoints will be specified in the individual research projects that will utilize the blood samples as a control group.
Collection of urine samples from healthy volunteers to serve as a healthy control group.
Time Frame: 1 day
There are no primary endpoints planned; endpoints will be specified in the individual research projects that will utilize the urine samples as a control group.